Tempest Therapeutics, Inc. will hold a special meeting on October 14, 2026, for stockholders to vote on a proposal.

Sep 16, 2026, 4:43 PM ETPaperworkRead the original at sec.gov

Neutral

Tempest adjourned its shareholder vote after not getting enough votes; it will reconvene and solicit more proxies, so this leaves the company's situation unchanged for now.

TPST · Tempest Therapeutics, Inc.

AI read · Neutral

The AI's read

The failed vote shows some stockholders did not support the proposed charter change. The company set a new meeting date and hired a proxy solicitor to try to get more votes. Those steps preserve the proposal's chance without changing Tempest's business today.

Get alerts for TPST

Follow Tempest Therapeutics, Inc. (TPST) free. When we publish a story about it, you get the plain-English explanation as an alert.

Get alerts for TPST

Free on the App Store and Google Play, or on the web.